Skip to contentB
Biofrontera Inc.
B
BFRIBiofrontera Inc. Q2 2025 · 10-Q
Revenue$9.03M$9.03M+15.2% vs Q2 2024 Net Income-$5.32M-$5.32MN/M vs Q2 2024 EPS Diluted-$0.57-$0.57N/M vs Q2 2024 Operating Income-$5,079,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$3,046,000N/M Margins · derivedOperating margin-56.2%+8.4 pt vs Q2 2024
Net margin-59.0%−55.7 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end